Verde Rello, ZoraidaSantiago Dorrego, CatalinaChicharro García, Luis MiguelReinoso Barbero, LuisTejerina, AntonioBandrés Moya, FernandoGómez Gallego, Félix2016-10-302016-10-302016Verde, Z., Santiago, C., Chicharro, L. M., Reinoso-Barbero, L., Tejerina, A., Bandrés, F., & Gómez-Gallego, F. (2016). Effect of Genetic Polymorphisms and Long-Term Tobacco Exposure on the Risk of Breast Cancer. International Journal of Molecular Sciences, 17(10), 1726. DOI: 10.3390/ijms1710172614220067http://hdl.handle.net/11268/5936Tobacco smoke contains many potentially harmful compounds that may act differently and at different stages in breast cancer development. The focus of this work was to assess the possible role of cigarette smoking (status, dose, duration or age at initiation) and polymorphisms in genes coding for enzymes involved in tobacco carcinogen metabolism (CYP1A1, CYP2A6) or inDNArepair (XRCC1, APEX1, XRCC3 and XPD) in breast cancer development. Methods: We designed a case control study with 297 patients, 217 histologically verified breast cancers (141 smokers and 76 non-smokers) and 80 healthy smokers in a cohort of Spanish women. Results: We found an association between smoking status and early age at diagnosis of breast cancer. Among smokers, invasive carcinoma subtype incidence increased with intensity and duration of smoking (all Ptrend < 0.05). When smokers were stratified by smoking duration, we only observed differences in long-term smokers, and the CYP1A1 Ile462Ile genotype was associated with increased risk of breast cancer (OR = 7.12 (1.98–25.59)). Conclusions: Our results support the main effect of CYP1A1 in estrogenic metabolism rather than in tobacco carcinogen activation in breast cancer patients and also confirmed the hypothesis that CYP1A1 Ile462Val, in association with long periods of active smoking, could be a breast cancer risk factor.engAtribución-NoComercial-SinDerivadas 4.0 Españahttp://creativecommons.org/licenses/by-nc-nd/4.0journal article10.3390/ijms17101726open accessGenéticaGenética